ARCHIVES

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

This article is from The Cancer Letter archive.

Vol. 25 No. 30 | July 30, 1999

Download PDF Visit The Full Archive

Related Articles

NCI Picks 11 Centers For Chemical Biology Consortium

October 23, 2009

Study Seeks Newly Diagnosed Prostate Cancer Patients

March 26, 2010

Hopkins Begins Review Of All Studies After OHRP Lifts Research Suspension.

July 27, 2001

CMS Develops New Math of Medicare: Reimbursement Money for Outcomes Data.

February 4, 2005

NCI to Ask Cancer Panel, NCAB, to Help Respond To Request for Review Of National Cancer Program

December 4, 1992

NTP Board Considers Modification Of Human Risk Statement, Adopts Plan For Chemical Selection

November 7, 1980